Author:
Haldar Nibedita,Chattopadhyay Santwana,Roy Atanu
Publisher
Akshantala Enterprises Private Limited
Reference22 articles.
1. [1] Mda CG, Steigenualt AG, Morey RE, et al. Characterizatiiru if three new enterococcal species, enterococcus sp. nov. CDC PNS-E1, enterococcus sp. Nov. CDC PNS-E2, and enterococcus sp. nov. CDC PNSE3, isolated from human clinical specimens. J Clin Microbiol 2004;42(3):11992-8.
2. [2] Teixeria LM, Facklam RR. Enterococcus. In: Borriello SP, Murray PR, Funke G, (eds). Topley & Wilson's microbiology & microbial infections. Bacteriology 10th edn. Hodder Arnold, London 2005:882-902.
3. [3] Mittal S, Singla P, Bala K, et al. Vancomycin and high level aminoglycoside resistance in enterococcus species in a tertiary health care centre: a therapeutic concern. J Pathogens 2016:5.
4. [4] NNIS System. National nosocomial infections surveillance (NNIS) system report, data summary from January 1990-May 1999, issued june 1999. A report from the NNIS system. Am J Infect Control 1999;27(6):520-32.
5. [5] Mathur P, Kapil A, Chandra R, et al. Antimicrobial resistance in enterococcus faecalis at a tertiary care centre of northern India. Indian J Med Res 2003;118:25-8.